Lai Ghee Chuan, Cho Hongbaek, Bernhardt Thomas G
Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, United States of America.
PLoS Genet. 2017 Jul 27;13(7):e1006934. doi: 10.1371/journal.pgen.1006934. eCollection 2017 Jul.
Bacterial cells are typically surrounded by an net-like macromolecule called the cell wall constructed from the heteropolymer peptidoglycan (PG). Biogenesis of this matrix is the target of penicillin and related beta-lactams. These drugs inhibit the transpeptidase activity of PG synthases called penicillin-binding proteins (PBPs), preventing the crosslinking of nascent wall material into the existing network. The beta-lactam mecillinam specifically targets the PBP2 enzyme in the cell elongation machinery of Escherichia coli. Low-throughput selections for mecillinam resistance have historically been useful in defining mechanisms involved in cell wall biogenesis and the killing activity of beta-lactam antibiotics. Here, we used transposon-sequencing (Tn-Seq) as a high-throughput method to identify nearly all mecillinam resistance loci in the E. coli genome, providing a comprehensive resource for uncovering new mechanisms underlying PG assembly and drug resistance. Induction of the stringent response or the Rcs envelope stress response has been previously implicated in mecillinam resistance. We therefore also performed the Tn-Seq analysis in mutants defective for these responses in addition to wild-type cells. Thus, the utility of the dataset was greatly enhanced by determining the stress response dependence of each resistance locus in the resistome. Reasoning that stress response-independent resistance loci are those most likely to identify direct modulators of cell wall biogenesis, we focused our downstream analysis on this subset of the resistome. Characterization of one of these alleles led to the surprising discovery that the overproduction of endopeptidase enzymes that cleave crosslinks in the cell wall promotes mecillinam resistance by stimulating PG synthesis by a subset of PBPs. Our analysis of this activation mechanism suggests that, contrary to the prevailing view in the field, PG synthases and PG cleaving enzymes need not function in multi-enzyme complexes to expand the cell wall matrix.
细菌细胞通常被一种称为细胞壁的网状大分子所包围,该细胞壁由杂聚物肽聚糖(PG)构建而成。这种基质的生物合成是青霉素及相关β-内酰胺类药物的作用靶点。这些药物抑制称为青霉素结合蛋白(PBPs)的PG合成酶的转肽酶活性,阻止新生壁材料交联到现有的网络中。β-内酰胺类药物美西林专门作用于大肠杆菌细胞伸长机制中的PBP2酶。历史上,针对美西林耐药性的低通量筛选在确定细胞壁生物合成机制和β-内酰胺类抗生素杀伤活性方面一直很有用。在这里,我们使用转座子测序(Tn-Seq)作为一种高通量方法来鉴定大肠杆菌基因组中几乎所有的美西林耐药位点,为揭示PG组装和耐药性的新机制提供了一个全面的资源。先前已表明,严格反应或Rcs包膜应激反应的诱导与美西林耐药性有关。因此,除了野生型细胞外,我们还对这些反应缺陷的突变体进行了Tn-Seq分析。因此,通过确定耐药组中每个耐药位点的应激反应依赖性,大大提高了数据集的实用性。我们推断,与应激反应无关的耐药位点最有可能识别细胞壁生物合成的直接调节因子,因此我们将下游分析集中在耐药组的这一子集上。对其中一个等位基因的表征导致了一个惊人的发现,即切割细胞壁交联的内肽酶的过量产生通过刺激一部分PBPs的PG合成来促进美西林耐药性。我们对这种激活机制的分析表明,与该领域的普遍观点相反,PG合成酶和PG切割酶不一定需要在多酶复合物中发挥作用来扩展细胞壁基质。